Why is Indrayani Biotec falling/rising?

As of 15-Jul, Indrayani Biotech Ltd's stock price is currently at 13.95, reflecting a decrease of 0.07 or 0.5%. The stock has been experiencing a downward trend, having fallen for the last two days with a total return decline of 11.15% during this period. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a weak performance. Additionally, while the stock has seen a significant increase in delivery volume, rising by 271.4% against the 5-day average, its long-term fundamentals remain weak, with an operating loss and a high Debt to EBITDA ratio of 9.25 times. The stock has generated a staggering return of -73.25% over the past year, and profits have plummeted by 134.9%, contributing to its negative outlook.
In the broader market context, Indrayani Biotech's short-term performance has significantly underperformed compared to the benchmark, with a 10.86% decline over the past week versus a 1.36% decline in the Sensex. This stark contrast highlights the company's struggles relative to the market. Furthermore, institutional investors have reduced their stake in the company by 1.59%, indicating a lack of confidence in its future prospects. Overall, the combination of poor financial performance, weak investor sentiment, and underperformance against the benchmark contributes to the ongoing decline in Indrayani Biotech's stock price.